In the BioHarmony Drug Report Database

"Preview" Icon

Promazine

Sparine (promazine) is a small molecule pharmaceutical. Promazine was first approved as Sparine on 1982-01-01. It is used to treat nausea, psychotic disorders, schizophrenia, and vomiting in the USA. The pharmaceutical is active against D(2) dopamine receptor and D(3) dopamine receptor. In addition, it is known to target major prion protein.

 

Trade Name

 

Sparine
 

Common Name

 

promazine
 

ChEMBL ID

 

CHEMBL564
 

Indication

 

nausea, psychotic disorders, schizophrenia, vomiting
 

Drug Class

 

Typical antipsychotic

Image (chem structure or protein)

Promazine structure rendering